Association of two polymorphisms of tumor necrosis factor gene with acute biliary pancreatitis

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 824-828

  Zhang, Dian Liang ^a   Li, Jie Shou ^a   Jiang, Zhi Wei ^a   Yu, Bao Jun ^a   Tang, Xing Ming ^a   Zheng, Hong Mei ^b  

^a NANJING UNIVERSITY   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; LYMPHOTOXIN; POLYACRYLAMIDE GEL; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR 1; TUMOR NECROSIS FACTOR 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BETA 1; TUMOR NECROSIS FACTOR BETA 2; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERIPHERAL CIRCULATION; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEPTIC SHOCK;

EID: 0037624554     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.824     Document Type: Article

References (33)

1. Forsmark CE. The clinical problem of biliary acute necrotizing pancreatitis: Epidemioloty, pathophysiology, and diagnosis of biliary necrotizing pancreatitis. J Gastrointest Surg 2001; 5: 235
2. Schmid SW, Buchler MW. The role of infection in acute pancreatitis. Gut 1999; 45: 311-316
3. Xia Q, Jiang JM, Gong X, Chen GY, Li L, Huang ZW. Experimental study of Tong Xia purgative method in ameliorating lung injury in acute necrotizing pancreatitis. World J Gastroenterol 2000; 6: 115-118
4. Grewal HP, Kotb M, El Din AM, Ohman M, Salem A, Gaber L, Gaber AO. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994; 115: 213-221
5. Chiche JD, Siami S, Dhainaut JF, Mira JP. Cytokine polymorphisms and susceptibility to severe infectious disease. Sepsis 2001; 4: 209-215
6. Wilson AG, De Vries N, Pociot F, Di Giovine FS, Van Der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560
7. McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumor necrosis-α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 1996; 26: 2113-2118
8. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-231
9. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor α promotor polymorphism effects transcription. Mol Immunol 1997; 34: 391-399
10. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199
11. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett 1996; 215: 75-78
12. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF-α)-308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1996; 46: 32-41
13. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510
14. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264
15. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174: 878-880
16. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riche F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multicenter study. JAMA 1999; 282: 561-568
17. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, Weiss EH. Polymorphic structure of the tumor necrosis factor (TNF) locus: An Ncol polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 1991; 173: 209-219
18. Stuber F, Petersen M, Bokelman F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384
19. Dominguez-Munoz JE, Carballo F, Garcia MJ, De Diego JM, Campos R, Yanguela J, De La Morena J. Evaluation of the clinical usefulness of APACHEII and SAPS systems in the initial prognostic classification of acute pancreatitis: A multicenter study. Pancreas 1993; 8: 682-686
20. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: Value of CT in establishing prognosis. Radiology 1990; 174: 331-336
21. Muckatt DJ, Bhagwanjee S. American College of Chest Physicians/Society of Ccritical Care Medicine consensus conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 1997; 25: 1789-1795
22. Zhang D, Li J, Jiang Z, Yu B, Tang X. Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis. Zhonghua Yixue Zazhi 2002; 82: 1529-1531
23. Sargen K, Demaine AG, Kingsnorth AN. Cytokine gene polymorphisms in acute pancreatitis. JOP 2000; 1: 24-35
24. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996; 83: 349-353
25. Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: An early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999; 27: 749-755
26. Majetschak M, Flohe S, Obertacke U, Schroder J, Staubach K, Nast-Kolb D, Schade FU, Stuber F. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999; 230: 207-214
27. Stüber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promotor. J Inflam 1996; 46: 42-50
28. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP, Vandenbroucke JP. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-173
29. Van Der Linden MW, Huizinga TW, Stoecken DJ, Sturk A, Westendorp RG. Determination of tumor necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: Assessment of laboratory error and individual variation. J Immunol Methods 1998; 218: 63-71
30. Kaufmann P, Tilz GP, Lueger A, Demel U. Elevated plasma levels of soluble tumor necrosis factor receptors (sTNFp60) reflect severity of acute pancreatitis. Intensive Care Med 1997; 23: 841-848
31. Steer ML. How and where does acute pancreatitis begin? Arch Surg 1992; 127: 1350-1353
32. Dominguez-Munoz JE, Carballo F, Garcia MJ, De Diego JM, Rabago L, Simon MA, De La Morena J. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: Results of a multicentre study. Br J Surg 1991; 78: 1230-1234
33. Powell JJ, Fearon KC, Siriwardena AK, Ross JA. Evidence against a role for polymorphisms at tumor necrosis factor interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001; 129: 633-640